Literature DB >> 32533108

Author Correction: Complement as a target in COVID-19?

Antonio M Risitano1, Dimitrios C Mastellos2, Markus Huber-Lang3, Despina Yancopoulou4, Cecilia Garlanda5,6, Fabio Ciceri7, John D Lambris8.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 32533108      PMCID: PMC7290154          DOI: 10.1038/s41577-020-0366-6

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


Nature Reviews Immunology (2020) 10.1038/s41577-020-0320-7 Published online 23 April 2020 In the originally published article, Cecilia Garlanda’s affiliations were incompletely listed as 5Humanitas Clinical and Research Center, Milan, Italy and 6Humanitas University, Milan, Italy. These have now been corrected to 5Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy and 6Humanitas University, Pieve Emanuele, Milan, Italy.
  10 in total

1.  Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19.

Authors:  Richard Dannebaum; Phillip Suwalski; Hosseinali Asgharian; Gracie Du Zhipei; Hai Lin; January Weiner; Manuel Holtgrewe; Charlotte Thibeault; Melina Müller; Xiaomin Wang; Zehra Karadeniz; Jacopo Saccomanno; Jan-Moritz Doehn; Ralf-Harto Hübner; Bernd Hinzmann; Anja Blüher; Sandra Siemann; Dilduz Telman; Norbert Suttorp; Martin Witzenrath; Stefan Hippenstiel; Carsten Skurk; Wolfgang Poller; Leif E Sander; Dieter Beule; Florian Kurth; Toumy Guettouche; Ulf Landmesser; Jan Berka; Khai Luong; Florian Rubelt; Bettina Heidecker
Journal:  EClinicalMedicine       Date:  2022-05-14

2.  Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome.

Authors:  Marisol Perez-Toledo; Sian E Faustini; Sian E Jossi; Adrian M Shields; Hari Krishnan Kanthimathinathan; Joel D Allen; Yasunori Watanabe; Margaret Goodall; David C Wraith; Tonny V Veenith; Mark T Drayson; Deepthi Jyothish; Eslam Al-Abadi; Ashish Chikermane; Steven B Welch; Kavitha Masilamani; Scott Hackett; Max Crispin; Barnaby R Scholefield; Adam F Cunningham; Alex G Richter
Journal:  medRxiv       Date:  2020-06-07

Review 3.  Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.

Authors:  Anita Gupta; G S Gupta
Journal:  Mol Cell Biochem       Date:  2021-03-21       Impact factor: 3.396

Review 4.  Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19.

Authors:  Rahul Kumar; Michael H Lee; Claudia Mickael; Biruk Kassa; Qadar Pasha; Rubin Tuder; Brian Graham
Journal:  ERJ Open Res       Date:  2020-12-07

Review 5.  Disease-drug and drug-drug interaction in COVID-19: Risk and assessment.

Authors:  Devendra Kumar; Neerja Trivedi
Journal:  Biomed Pharmacother       Date:  2021-04-27       Impact factor: 7.419

6.  Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems.

Authors:  Kavitha Mukund; Kalai Mathee; Shankar Subramaniam
Journal:  IEEE Open J Eng Med Biol       Date:  2020-08-06

7.  Association of mortality and endothelial dysfunction with serum ADMA level in COVID-19 patients.

Authors:  Cengiz Karacaer; Selcuk Yaylaci; Taner Demirci; Deniz Cekic; Kezban Ozmen Suner; Erdem Cokluk; Ceyhun Varim
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

Review 8.  Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19.

Authors:  Ronen Alon; Mike Sportiello; Stav Kozlovski; Ashwin Kumar; Emma C Reilly; Alexander Zarbock; Natalio Garbi; David J Topham
Journal:  Nat Rev Immunol       Date:  2020-11-19       Impact factor: 53.106

9.  Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.

Authors:  Xin Hou; Xiaomei Zhang; Xian Wu; Minya Lu; Dan Wang; Meng Xu; Hongye Wang; Te Liang; Jiayu Dai; Hu Duan; Yingchun Xu; Xiaobo Yu; Yongzhe Li
Journal:  Mol Cell Proteomics       Date:  2020-08-11       Impact factor: 5.911

Review 10.  Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.

Authors:  Ludmila Lupu; Annette Palmer; Markus Huber-Lang
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.